IGC: IGC Pharma, Inc. Stock

by  •  • Comments Off on IGC: IGC Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.07
Enterprise Value ($M) 27.84
Book Value ($M) 9.05
Book Value / Share 0.14
Price / Book 3.21
NCAV ($M) 1.38
NCAV / Share 0.02
Price / NCAV 21.11

Profitability (mra)
Return on Invested Capital (ROIC) -1.50
Return on Assets (ROA) -0.82
Return on Equity (ROE) -0.95

Liquidity (mrq)
Quick Ratio 0.86
Current Ratio 1.85

Balance Sheet (mrq) ($M)
Current Assets 3.58
Assets 11.26
Liabilities 2.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-07-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-15 141,530 400,983 35.30
2024-04-12 313,448 69,733 449.50
2024-04-11 82,122 31,596 259.91
2024-04-10 232,642 63,990 363.56

(click for more detail)

Similar Companies
CVM – CEL-SCI Corporation CYBN – Cybin Inc.
IBIO – iBio, Inc. LCTX – Lineage Cell Therapeutics, Inc.
MAIA – MAIA Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io